A framework for evaluating unexpected reactions in antibody-drug conjugates during clinical development: a case study of a promiscuous payload

Eef H. C. Dirksen, Marijn Buurman, Jeroen Kooistra, Benno Ingelse, Ruud Ubink · 2026

Read A framework for evaluating unexpected reactions in antibody-drug conjugates during clinical development: a case study of a promiscuous payload by Eef H. C. Dirksen, Marijn Buurman, Jeroen Kooistra, Benno Ingelse, Ruud Ubink (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13596894.txt.

Description

Dirksen, Ubink and their co-authors set out a framework for judging surprise reactions in antibody-drug conjugates during drug development. Their work, listed for 2026, uses a real case where a stored product lost much of its killing power.

These drugs join an antibody to a small toxic payload by a linker. Tests found a cross-link had formed inside one product, tying the linker-drug to part of the antibody, and that link wiped out its cell-killing effect. The same link also formed in the body, but its effect on drug levels was small. The authors offer their steps as a general guide for risk checks.

Catalog record

CREATOREef H. C. Dirksen, Marijn Buurman, Jeroen Kooistra, Benno Ingelse, Ruud Ubink
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13596894

Browse the full library · About the Tower of Babel